Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

STREPTOZOCIN for Insulinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where STREPTOZOCIN was used for Insulinoma.

Most Reported Side Effects for STREPTOZOCIN

Side Effect Reports % Deaths Hosp.
Malignant neoplasm progression 31 17.6% 3 20
Product use in unapproved indication 29 16.5% 6 13
Drug ineffective 25 14.2% 3 8
Toxicity to various agents 24 13.6% 8 0
Hypoglycaemia 23 13.1% 1 12
Nausea 23 13.1% 0 18
Nephropathy toxic 23 13.1% 0 0
Off label use 23 13.1% 10 8
Chronic kidney disease 22 12.5% 0 0
Fatigue 22 12.5% 1 12
Pancreatic neuroendocrine tumour 21 11.9% 0 16
Cardiac failure 17 9.7% 12 7
Disease progression 17 9.7% 5 2
Left ventricular dysfunction 16 9.1% 9 0
Decreased appetite 13 7.4% 0 11

Other Indications for STREPTOZOCIN

Pancreatic neuroendocrine tumour (90) Neuroendocrine tumour (18) Pancreatic neuroendocrine tumour metastatic (17) Product used for unknown indication (9) Adrenocortical carcinoma (6) Metastases to liver (5)

Other Drugs Used for Insulinoma

OCTREOTIDE (72) DIAZOXIDE (43) TEMOZOLOMIDE (37) EVEROLIMUS (34) CAPECITABINE (28) PASIREOTIDE (17) LANREOTIDE (14) FLUOROURACIL (13) LUTETIUM OXODOTREOTIDE LU-177 (13) OCTREOTIDE\OCTREOTIDE (10)

Related Pages

STREPTOZOCIN Full Profile All Insulinoma Drugs STREPTOZOCIN Demographics STREPTOZOCIN Timeline